Comments

CARISMA Therapeutics

CARMNASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$1.13
-0.06-5.04%
At Close: -
$1.15
0.021.77%
After Hours: 4:29 PM EDT
15 minutes delayed
CARISMA Therapeutics (CARM) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

CARISMA Therapeutics (NASDAQ:CARM) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for CARISMA Therapeutics (CARM)?

A

There have been no specific sales or earnings guidance reported for CARISMA Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch